Immunic, Inc.
IMUX· Nasdaq
Released Oct 25, 2017, after the close
10-Q filed Oct 25, 2017, 25 days after period end · 0001280776-17-000098
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Net Income | -$12.48M | -$10.18M | -$12.30M | -$12.80M |
| EPS Diluted | -$0.30 | -$0.32 | -$0.51 | -$0.59 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR